OpenVSafe by OpenVAERS
Search V-safe

N3T-31926-65681

3 vaccinations 1 coded response 20 check-ins 0 free-text entries 1 call case
Sex
Female
Age at first dose
21-25
ZIP prefix
296 / SC
Registered
2020-12-31
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-29
    Dose 1 — Pfizer-BioNTech
  2. 2020-12-31
    Registered in v-safe
  3. 2020-12-31
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-01-01
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-01-02
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-01-03
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-04
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-05
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-01-12
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  10. 2021-01-15
    Dose 2 — Pfizer-BioNTech
  11. 2021-01-26
    Health check-in — day 7, dose 2
    Feeling: Good · Site: Pain · Headache, Fatigue or tiredness, Nausea, Vomiting
    Adult check-in
  12. 2021-01-31
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-02-05
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-02-12
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-02-19
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-02-26
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-04-16
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-07-16
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  19. 2022-01-15
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in
  20. 2022-04-08
    Dose 3 — Pfizer-BioNTech
  21. 2022-04-20
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  22. 2022-04-24
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  23. 2022-10-07
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  24. 2023-04-08
    Survey response — 12 months, dose 3
    MedDRA: Abortion spontaneous, Uterine dilation and curettage — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional
    MedDRA releases: 2024-11
  25. 2023-04-08
    Report sent to call center — 12 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  26. 2023-04-10

Vaccinations

DoseDateManufacturerCo-administered
12020-12-29Pfizer-BioNTech
22021-01-15Pfizer-BioNTech
32022-04-08Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2023-04-08 Unsuccessful

Free text

None.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOUterine dilation and curettage · · ✓
SDAbortion spontaneous · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release